Cargando…
Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis
BACKGROUND: Health systems need to optimize the use of resources, especially in high-cost diseases as rheumatoid arthritis (RA). We aimed to evaluate the efficiency of using centers of excellence (CoE) as a strategy for improving RA treatment in Colombia. METHODS: A cost description analysis was car...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236254/ https://www.ncbi.nlm.nih.gov/pubmed/34188503 http://dx.doi.org/10.2147/CEOR.S308024 |
_version_ | 1783714501215911936 |
---|---|
author | Santos-Moreno, Pedro Alvis-Zakzuk, Nelson J Villarreal-Peralta, Laura Carrasquilla-Sotomayor, Maria de la Hoz-Restrepo, Fernando Alvis-Guzmán, Nelson |
author_facet | Santos-Moreno, Pedro Alvis-Zakzuk, Nelson J Villarreal-Peralta, Laura Carrasquilla-Sotomayor, Maria de la Hoz-Restrepo, Fernando Alvis-Guzmán, Nelson |
author_sort | Santos-Moreno, Pedro |
collection | PubMed |
description | BACKGROUND: Health systems need to optimize the use of resources, especially in high-cost diseases as rheumatoid arthritis (RA). We aimed to evaluate the efficiency of using centers of excellence (CoE) as a strategy for improving RA treatment in Colombia. METHODS: A cost description analysis was carried out using the standard costing technique. We estimated the costs of medical consultations, laboratories, images, and medications for RA. Categories of care standards stratified by severity were defined using the disease activity score in 28 joints (DAS28). We evaluated the impact, in terms of costs (US dollars), for providing RA clinical care for a previously described cohort using the CoE approach. Statistical analyses were performed in Microsoft Excel(®), and R. RESULTS: Expenditure on therapeutic drugs increases as the severity of RA increases. Drugs represent 53.6% of the total cost for the low disease activity (LDA) stage, 75.2% for moderate disease activity (MDA), 88.5% for severe disease activity (SDA) and 97% for SDA with biologic treatment (SDA+Biologic). Treating 968 patients would cost US$612,639 (US$487,978–1,220,160) at baseline, per year. After a year of follow-up at the CoE, treating the same patients would cost US$388,765 (US$321,710–708,476), which implies potential cost-savings of up to US$223,874 per year. CONCLUSION: The strategy of providing clinical care for RA through CoE can save US$231.3 per patient-per year. The results of our study show that CoE could greatly impact the public policies dealing with treatment of RA in Colombia. Applying the CoE model in our country would both improve health outcomes, as well as being more efficient in terms of costs. |
format | Online Article Text |
id | pubmed-8236254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82362542021-06-28 Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis Santos-Moreno, Pedro Alvis-Zakzuk, Nelson J Villarreal-Peralta, Laura Carrasquilla-Sotomayor, Maria de la Hoz-Restrepo, Fernando Alvis-Guzmán, Nelson Clinicoecon Outcomes Res Original Research BACKGROUND: Health systems need to optimize the use of resources, especially in high-cost diseases as rheumatoid arthritis (RA). We aimed to evaluate the efficiency of using centers of excellence (CoE) as a strategy for improving RA treatment in Colombia. METHODS: A cost description analysis was carried out using the standard costing technique. We estimated the costs of medical consultations, laboratories, images, and medications for RA. Categories of care standards stratified by severity were defined using the disease activity score in 28 joints (DAS28). We evaluated the impact, in terms of costs (US dollars), for providing RA clinical care for a previously described cohort using the CoE approach. Statistical analyses were performed in Microsoft Excel(®), and R. RESULTS: Expenditure on therapeutic drugs increases as the severity of RA increases. Drugs represent 53.6% of the total cost for the low disease activity (LDA) stage, 75.2% for moderate disease activity (MDA), 88.5% for severe disease activity (SDA) and 97% for SDA with biologic treatment (SDA+Biologic). Treating 968 patients would cost US$612,639 (US$487,978–1,220,160) at baseline, per year. After a year of follow-up at the CoE, treating the same patients would cost US$388,765 (US$321,710–708,476), which implies potential cost-savings of up to US$223,874 per year. CONCLUSION: The strategy of providing clinical care for RA through CoE can save US$231.3 per patient-per year. The results of our study show that CoE could greatly impact the public policies dealing with treatment of RA in Colombia. Applying the CoE model in our country would both improve health outcomes, as well as being more efficient in terms of costs. Dove 2021-06-23 /pmc/articles/PMC8236254/ /pubmed/34188503 http://dx.doi.org/10.2147/CEOR.S308024 Text en © 2021 Santos-Moreno et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Santos-Moreno, Pedro Alvis-Zakzuk, Nelson J Villarreal-Peralta, Laura Carrasquilla-Sotomayor, Maria de la Hoz-Restrepo, Fernando Alvis-Guzmán, Nelson Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title | Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title_full | Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title_fullStr | Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title_full_unstemmed | Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title_short | Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis |
title_sort | centers of excellence implementation for treating rheumatoid arthritis in colombia: a cost-analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236254/ https://www.ncbi.nlm.nih.gov/pubmed/34188503 http://dx.doi.org/10.2147/CEOR.S308024 |
work_keys_str_mv | AT santosmorenopedro centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis AT alviszakzuknelsonj centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis AT villarrealperaltalaura centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis AT carrasquillasotomayormaria centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis AT delahozrestrepofernando centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis AT alvisguzmannelson centersofexcellenceimplementationfortreatingrheumatoidarthritisincolombiaacostanalysis |